62 related articles for article (PubMed ID: 24938715)
1. Diabetes mellitus potentiates diffuse large B‑cell lymphoma via high levels of CCL5.
Zhang J; Luo J; Liu F; Wu D; Zhong Q; Zeng L; Wu Z; Zhao T; Wu L; Hao H
Mol Med Rep; 2014 Sep; 10(3):1231-6. PubMed ID: 24938715
[TBL] [Abstract][Full Text] [Related]
2. [Relationship between Chemotactic Factor CCL5 and Diabet-associated Diffuse Large B Cell Lymphoma].
Zhang JC; Liu FR; Hu HX; He F; Tu Y; Wei B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1325-30. PubMed ID: 26524031
[TBL] [Abstract][Full Text] [Related]
3. Analysis of CCL5 expression in classical Hodgkin's lymphoma L428 cell line.
Liu F; Zhang Y; Wu ZQ; Zhao T
Mol Med Rep; 2011; 4(5):837-41. PubMed ID: 21701779
[TBL] [Abstract][Full Text] [Related]
4. [Establishment and characterization of a nude mice model of human diffuse large B-cell lymphoma].
Yu BH; Zhou XY; Zhang TC; Zhang TM; Shi DR
Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):246-50. PubMed ID: 21615998
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-9 promotes cell survival and drug resistance in diffuse large B-cell lymphoma.
Lv X; Feng L; Ge X; Lu K; Wang X
J Exp Clin Cancer Res; 2016 Jul; 35(1):106. PubMed ID: 27364124
[TBL] [Abstract][Full Text] [Related]
6. Arsenic disulfide induces apoptosis of human diffuse large B cell lymphoma cells involving Bax cleavage.
Wang L; Liu X; Li X; Lv X; Lu K; Chen N; Li P; Wang X
Oncol Rep; 2013 Nov; 30(5):2427-34. PubMed ID: 24026139
[TBL] [Abstract][Full Text] [Related]
7. Mutations of the PIK3CA gene in diffuse large B cell lymphoma.
Baohua Y; Xiaoyan Z; Tiecheng Z; Tao Q; Daren S
Diagn Mol Pathol; 2008 Sep; 17(3):159-65. PubMed ID: 18382359
[TBL] [Abstract][Full Text] [Related]
8. BAL1/ARTD9 represses the anti-proliferative and pro-apoptotic IFNγ-STAT1-IRF1-p53 axis in diffuse large B-cell lymphoma.
Camicia R; Bachmann SB; Winkler HC; Beer M; Tinguely M; Haralambieva E; Hassa PO
J Cell Sci; 2013 May; 126(Pt 9):1969-80. PubMed ID: 23487038
[TBL] [Abstract][Full Text] [Related]
9. MYD88 expression and L265P mutation in diffuse large B-cell lymphoma.
Choi JW; Kim Y; Lee JH; Kim YS
Hum Pathol; 2013 Jul; 44(7):1375-81. PubMed ID: 23380077
[TBL] [Abstract][Full Text] [Related]
10. CDK6 overexpression resulted from microRNA‑320d downregulation promotes cell proliferation in diffuse large B‑cell lymphoma.
Su H; Chang J; Xu M; Sun R; Wang J
Oncol Rep; 2019 Jul; 42(1):321-327. PubMed ID: 31059102
[TBL] [Abstract][Full Text] [Related]
11. Tumor-derived CCL5 does not contribute to breast cancer progression.
Jayasinghe MM; Golden JM; Nair P; O'Donnell CM; Werner MT; Kurt RA
Breast Cancer Res Treat; 2008 Oct; 111(3):511-21. PubMed ID: 17978871
[TBL] [Abstract][Full Text] [Related]
12. Tumor-derived chemokine CCL5 enhances TGF-β-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells.
Chang LY; Lin YC; Mahalingam J; Huang CT; Chen TW; Kang CW; Peng HM; Chu YY; Chiang JM; Dutta A; Day YJ; Chen TC; Yeh CT; Lin CY
Cancer Res; 2012 Mar; 72(5):1092-102. PubMed ID: 22282655
[TBL] [Abstract][Full Text] [Related]
13. Reduction of CC-chemokine ligand 5 by aryl hydrocarbon receptor ligands.
Morino-Koga S; Uchi H; Tsuji G; Takahara M; Kajiwara J; Hirata T; Furue M
J Dermatol Sci; 2013 Oct; 72(1):9-15. PubMed ID: 23810773
[TBL] [Abstract][Full Text] [Related]
14. [Expressions of bcl-6, lpp and miR-28 genes in diffuse large B cell lymphoma cell lines].
Xu W; Li JY; Fan L; Qiao C; Yu H; Shen QD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):83-7. PubMed ID: 19236753
[TBL] [Abstract][Full Text] [Related]
15. Hedgehog signaling pathway is activated in diffuse large B-cell lymphoma and contributes to tumor cell survival and proliferation.
Singh RR; Kim JE; Davuluri Y; Drakos E; Cho-Vega JH; Amin HM; Vega F
Leukemia; 2010 May; 24(5):1025-36. PubMed ID: 20200556
[TBL] [Abstract][Full Text] [Related]
16. CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.
Wang SW; Liu SC; Sun HL; Huang TY; Chan CH; Yang CY; Yeh HI; Huang YL; Chou WY; Lin YM; Tang CH
Carcinogenesis; 2015 Jan; 36(1):104-14. PubMed ID: 25330803
[TBL] [Abstract][Full Text] [Related]
17. [Effects of down-regulation of CC chemokine ligand 5 (CCL5) on proliferation of human breast cancer cells in vitro].
Kuang JX; Wang WX; Sun SR; Wang WR; Yao XL
Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):174-7. PubMed ID: 21575514
[TBL] [Abstract][Full Text] [Related]
18. Preliminary study on decreasing the expression of FOXP3 with miR-155 to inhibit diffuse large B-cell lymphoma.
Zhang J; Wei B; Hu H; Liu F; Tu Y; Zhao M; Wu D
Oncol Lett; 2017 Aug; 14(2):1711-1718. PubMed ID: 28789399
[TBL] [Abstract][Full Text] [Related]
19. Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL).
Cycon KA; Rimsza LM; Murphy SP
Exp Hematol; 2009 Feb; 37(2):184-194. PubMed ID: 19081173
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of BACH2 expression in diffuse large B-cell lymphoma: a study of the Osaka Lymphoma Study Group.
Sakane-Ishikawa E; Nakatsuka S; Tomita Y; Fujita S; Nakamichi I; Takakuwa T; Sugiyama H; Fukuhara S; Hino M; Kanamaru A; Soma T; Tsukaguchi M; Igarashi K; Kanakura Y; Aozasa K;
J Clin Oncol; 2005 Nov; 23(31):8012-7. PubMed ID: 16258099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]